ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.0990
0.00 (0.00%)
At close: Aug 18, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $801.5 thousand as of August 19, 2026. Its market cap has decreased by -35.90% in one year.
Market Cap
801.50K
Enterprise Value
1.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
ChartMarket Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 801.50K, a decrease of -99.16%. That is a compound annual growth rate of -65.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 801.50K | -25.90% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.04M |
| Evofem Biosciences | 997.16K |
| Avenue Therapeutics | 848.78K |
| Emmaus Life Sciences | 807.17K |
| Agentix | 801.34K |
| Nextel Medical | 739.38K |
| SQZ Biotechnologies Company | 707.79K |
| Regenerative Medical Technology Group | 696.37K |